Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Chr. Olesen Synthesis
organization2 mentionslast seen Oct 2, 2026
Danish developer and manufacturer of active pharmaceutical ingredients specialising in controlled substances.
Relationships 11
- SamfaraacquiresChr. Olesen Synthesis99% confidence2 sources
- Chr. OlesenacquiresChr. Olesen Synthesis97% confidence1 source
- Chr. Olesen SynthesisemploysThomas Moestrup96% confidence1 source
- Chr. Olesen Synthesisdevelopsactive pharmaceutical ingredient96% confidence1 source
- Samfarainvests inChr. Olesen Synthesis95% confidence1 source
- Chr. Olesen Synthesisdevelopslisdexamfetamine93% confidence1 source
- Chr. Olesen Synthesisdevelopsbuprenorphine93% confidence1 source
- Thomas Moestrupinvests inChr. Olesen Synthesis93% confidence1 source
- Chr. Olesen Synthesisapplies tocontrolled-substance API manufacturing85% confidence1 source
- Signet Healthcare Partnersinvests inChr. Olesen Synthesis75% confidence1 source
- Chr. OlesensuppliesChr. Olesen Synthesis70% confidence1 source
Relationship
SamfaraacquiresChr. Olesen Synthesis
99% confidence2 supporting mentionsfrom Oct 2, 2026
Either name opens that entity’s relationships.
Sources 2
- newsPR NewswireOct 2, 2026Samfara completes acquisition of Chr. Olesen Synthesis, Danish manufacturer of controlled-substance APIs
Samfara, a European life sciences investment firm, today announced that it has completed the acquisition of Chr. Olesen Synthesis
- newsPR NewswireOct 2, 2026Samfara completes acquisition of Chr. Olesen Synthesis, Danish manufacturer of controlled-substance APIs
Samfara, a European life sciences investment firm, today announced that it has completed the acquisition of Chr. Olesen Synthesis